Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2009
11/05/2009WO2009135029A2 Compositions and methods to treat urinary incontinence
11/05/2009WO2009134383A2 Vinyl substituted fatty acids
11/05/2009WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
11/05/2009WO2009133861A1 Cyclic amine compound
11/05/2009WO2009133387A1 Indole- 3 -glyoxylamide derivatives for use as calcium ion channel modulators
11/05/2009WO2009053842A3 Prevention of recurrence of urethral stricture after a conventional treatment
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009US20090275571 Morpholinyl and pyrrolidinyl analogs
11/05/2009US20090275563 Combination of 5-HT7 Receptor Antagonist and Serotonin Reuptake Inhibitor Therapy
11/05/2009US20090275498 Novel peptides
11/05/2009US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009US20090274678 Compositions and methods to treat urinary incontinence
11/05/2009CA2729053A1 Vinyl substituted fatty acids
11/04/2009EP1620131B1 Ghrh for use in treating chronic renal failure
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1480736B1 Microcapsules having high carotenoid content
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009EP1372638B1 Cannabinoids for the treatment of breathing disorders during sleep
11/04/2009EP1011695B2 Use of neurotoxin therapy for treatment of prostate disorders
11/03/2009US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009US7612225 Endothelin receptor antagonist, useful for treating various circulatory system diseases such as hypertension, ischemic disorders, cerebral circulatory disorders, renal disorders, circulatory insufficiency of various organs, asthma, stroke
11/03/2009US7612113 Hydroxy tetrahydro-naphthalenylurea derivatives
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009US7611730 Containing racemate of tramadol in slow-release form and (+)enantiomer of tramadol in immediate-release form; analgesic efficacy results from interplay of enantiomers by mechanism which includes non-opioid and opiod components
11/03/2009US7611729 Dosage forms having prolonged active ingredient release
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009CA2383220C Controlled release pellet formulation
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
10/2009
10/29/2009WO2009131954A2 Compounds, compositions and methods comprising oxadiazole derivatives
10/29/2009WO2009131951A2 Compounds, compositions and methods comprising isoxazole derivatives
10/29/2009WO2009131947A2 Compounds, compositions and methods comprising pyridazine derivatives
10/29/2009WO2009131245A1 Iminopyridine derivatives and use thereof
10/29/2009WO2009131135A1 Iminopyridine derivative and use thereof
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009129945A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
10/29/2009US20090270634 hydrolyzing the brominated product of 1-methylhydantoin to form 5-hydroxy-1-methylimidazolidin-2,4-dione, drug such as for renal failure; purified product for renal patients
10/29/2009US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009US20090270406 Combination Therapy for the Treatment of Urinary Frequency, Urinary Urgency and Urinary Incontinence
10/29/2009US20090270398 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/29/2009US20090270393 Iminopyridine Derivatives and Use Thereof
10/29/2009US20090270380 3,4,5-Substituted Piperidines as Renin Inhibitors
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090269425 Formulation and method for relieving or preventing symptoms associated with uric acid crystals
10/29/2009CA2723216A1 Iminopyridine derivatives and use thereof
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722031A1 Iminopyridine derivative and use thereof
10/28/2009EP2112225A1 Recombinant pox virus for immunization against tumor-associated antigens
10/28/2009EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1404323B1 Use of methylnaltrexone to treat immune suppression
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009CN101568349A Methods of reducing phosphate absorption
10/28/2009CN101568334A Iron metabolism-improving agent
10/28/2009CN101564496A Plaster for mainly curing osteoarthropathy and soft tissue injury
10/28/2009CN101564494A Composition for nourishing kidney, tonifying energy, nourishing brain and allaying excitement, preparation method and quality control method
10/28/2009CN101564488A Traditional Chinese medicine for curing chronic prostatitis of old people
10/28/2009CN101564461A Method for preparing Chinese medicine used for clearing heat, moistening lung, relieving cough, resolving phlegm, disinhibiting urine and freeing strangury
10/28/2009CN101564452A Method for preparing Chinese medicinal preparation for treating urinary system infection
10/28/2009CN101564449A Traditional Chinese medicine composition for curing chronic pyelonephritis
10/28/2009CN101564416A Chinese traditional medicine combination for curing nephritis
10/28/2009CN101564377A Oxybutynin transdermal gel and the preparation method thereof
10/28/2009CN101564075A Health tea for replenishing qi and reinforcing kidney of mid-aged and old people
10/28/2009CN100553667C Chinese medicine wine for strengthening physique, refreshing spirit and improving sexual function
10/28/2009CN100553645C Solid pipefish dispersion and its preparation method and application
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/28/2009CN100553623C Chinese caterpillar fungus formulation preparation method
10/28/2009CN100553475C Feed additive containing the fruit of Chinese wolfberry
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608577 Peptidyl ketones as inhibitors of DPIV
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608411 Prostaglandin receptor EP1
10/27/2009US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2454664C Cancer treatment with go6976 and its related compounds
10/27/2009CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives
10/27/2009CA2406044C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2381165C Novel quinuclidine derivatives and medicinal compositions containing the same
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/22/2009WO2009129501A1 Use of soluble epoxide hydrolase inhibitors in the treatment of smooth muscle disorders
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009128479A1 Imidazoline derivative
10/22/2009WO2009127686A1 Novel estrogen receptor ligands
10/22/2009WO2009127140A1 7p peptide and its derivant, the use thereof
10/22/2009WO2009108383A3 Substituted xanthine derivatives
10/22/2009WO2009099650A3 Treatment of bladder diseases with a tlr7 activator
10/22/2009US20090265798 Desaturase genes and uses thereof
10/22/2009US20090264486 Compounds, Compositions and Methods Comprising Isoxazole Derivatives
10/22/2009US20090264481 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/22/2009US20090264471 Compounds, Compositions and Methods Comprising Triazole Derivatives
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264396 17Alpha, 21-Dihydroxypregnene esters as antiandrogenic agents
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 562